Pharma R&D Today
Ideas and Insight supporting all stages of Drug Discovery & Development
Ann-Marie Roche
Director, Corporate Markets Marketing, Elsevier
Connect with Ann-Marie Roche on LinkedIn
Website: https://www.elsevier.com/
About the author:
An experienced and passionate global marketing leader in creating useful, usable and enjoyable customer experiences. I started my career as a researcher and after joining Elsevier, I have had the opportunity to get closer to the fascinating world of Life Sciences, which I now use to identify and further explore key issues such as data as a service, AI, data extraction and personalized medicine. My goal is to engage with my audience and support knowledge sharing and discussion.
Posts by Ann-Marie Roche
Reaxys Prize Winners Share Their Research Experiences and Advice
Posted on April 13th, 2021 in Chemistry
If there is one thing we at Elsevier have learned over the last 10 years of hosting the Reaxys PhD Prize, it’s that there are many different paths to research success. We have seen incredible work from scientists coming from a variety of backgrounds and experiences, and that was again evident with our three winning finalists for the 2020 Reaxys PhD Prize.
(more…)COVID-19 Treatment Trial Reaches Out to Communities of Color
Posted on April 5th, 2021 in COVID-19
An ongoing problem in clinical trials over the years has been a failure to procure diverse enough representation among the participants. For a long time, this was due to bias and oversight on the part of the research community, and the consequence was a lack of full understanding in how medications and treatments affected women and various racial/ethnic minorities.
(more…)FDA Introduces Data Modernization Action Plan
Posted on March 29th, 2021 in Pharma R&D
One of the frustrations of our Big Data era is that, despite the existence of an ever-growing wealth of valuable data, this data is often stuck in different silos. This lack of accessibility makes it hard to get the most out of data that has the potential to be extremely useful.
(more…)Harris Poll Finds Large Boost in Pharma Industry Reputation
Posted on March 15th, 2021 in Pharma R&D
As the COVID-19 vaccine roll-out gains in intensity, it has become common to hear people toss out the names of pharmaceutical companies like Pfizer, Moderna and AstraZeneca with the same ease that they refer to their favorite brands of ketchup or peanut butter. This isn’t typical. While direct-to-consumer advertising has perhaps increased some awareness of drug makers, the pandemic has made pharma R&D a subject of public interest in an unprecedented fashion.
(more…)
